J Clin Aesthet Dermatol. 2021;14(4):E61–E67. by Sanusi Umar, MD; Delphine J. Lee, MD, PhD; and Jenna J. Lullo, MD Dr. Umar is with the Department of Medicine at the University
J Clin Aesthet Dermatol. 2021;14(3):E53–E57. by Terry M. Jones, MD, and Iain Stuart, PhD Dr. Jones is with J&S Studies Inc., in College Station, Texas. Dr. Stuart is with VYNE
J Clin Aesthet Dermatol. 2021;14(3):E58–E62. by Tsioumas G. Sotiris, MD; Giulio Nittari, PhD; Getu Gamo Sagaro, Phd; and Francesco Amenta, MD Dr. Sotiris is with the Tsioumas Sotiris Clinic in
J Clin Aesthet Dermatol. 2021;14(2):E69–E88. by Riekie Smit, MD; Elena Gubanova, MD; Joely Kaufman, MD; Marina Landau, MD; Beatriz Molina, MD; Bill Andriopoulos, PhD; Pascal Maisonobe, MSc; Inna Prygova, MD;
J Clin Aesthet Dermatol. 2020;13(12):E53–E55 by Jihan Muhaidat, MD; Firas Al-Qarqaz, MD; and Diala Alshiyab, MD All authors are with the Department of Dermatology, Faculty of Medicine at Jordan University
J Clin Aesthet Dermatol. 2020;13(10) by Neal Bhatia, MD; Leon H. Kircik MD; Ava Shamban, MD; Varsha Bhatt, PhD; Radhakrishnan Pillai, PhD; and Eric Guenin, PharmD, PhD, MPH Dr. Bhatia
by Khairuddin Djawad, MD, PhD; Siswanto Wahab, MD, PhD; Olivia Wibisono, MD; Christina Avanti, PhD; Astridani R. Putranti, PhD; Agussalim Bukhari, MD, PhD; and Ilham J. Patellongi, MD, PhD Drs. Djawad,
by Zoe Diana Draelos, MD; Steven Hall, PharmD; and Carey Munsick, MS Dr. Draelos is with Dermatology Consulting Services, PLLC, in High Point, North Carolina. Dr. Hall and Ms. Munsick
by Davlouros Sotiris, MD; Graziano Pallotta, PhD, PharmD; Giulio Nittari, PhD, PharmD; and Francesco Amenta, MD
J Clin Aesthet Dermatol. 2020;13(7):E53–E57 by Daniele Maggioni, PhD; Annamaria Cimicata, MS; Antonella Praticò, MS; Roberta Villa, MS; Ferdinando Bianchi, MD; Silvia Busoli Badiale, MS; Umberto Piana; and Claudio Angelinetta
J Clin Aesthet Dermatol. 2020;13(7):E58–E63 by Patrícia Froes Meyer, PhD; Rodrigo Marcel Valentim da Silva, DO; Eneida de Morais Carreiro, MD; Bruna S. da Costa, BA; Débora Freire, BA; Júlio
J Clin Aesthet Dermatol. 2020;13(6):xx–xx by Sandrine Sebban, MD Dr. Sebban is in private practice in Paris, France. FUNDING: No funding was provided for this study. DISCLOSURES: The author owns
Background. Vitiligo is an acquired disorder characterized by depigmented macules or patches on the skin due to the loss of functional melanocytes. Segmental vitiligo (SV) is a subtype of vitiligo refractory to treatment.
Vascular occlusion has been cited as the most severe and feared early complication in aesthetic treatment1 and the incidence appears to be on the increase.
Objective: We assessed clinical effectiveness, longevity of treatment effects, and patient satisfaction with incobotulinumtoxinA for glabellar frown lines (GFL) treatment in Asian patients.
Background: Radiofrequency energy has been shown to penetrate deeper into the skin, independent of skin color, and to be beneficial for skin tightening.
Objective. We sought to evaluate the safety, tolerability, and patterns of use for the once-daily oral, narrow-spectrum antibiotic sarecycline in patients with moderate-to-severe acne vulgaris during a 40-week Phase III, multicenter, open-label extension study.
Background.Keratosis pilaris (KP) is a common benign follicular disorder for which various topical and laser treatments have been used, with limited efficacy.
Background.Seborrheic keratoses (SKs) are one of the most common benign epithelial tumors seen by dermatologists.
by Sharleen St. Surin-Lord, MD; Todd E. Schlesinger, MD, FAAD; and Eric Guenin, PharmD, PhD, MPH Dr. St. Surin-Lord is with Visage Dermatology and Aesthetics Center in Largo, Maryland. Dr. Schlesinger